EndoStim targets $36m IPO

October 1, 2014 By Alex Soule Leave a Comment

EndoStim said it hopes to raise nearly $36 million in an initial public offering, with plans to plow $10 million into clinical studies of its system to treat severe gastroesophageal reflux disease and another $14 million to commercialize the system.

EndoStim is operating from a small headquarters in St. Louis where it employs 13 people, including CEO Bevil Hogg, who took Stereotaxis (NSDQ:STXS) public in a 2004 IPO that raised $44 million.

Santé Health Ventures was the biggest contributor to some $26 million in funding EndoStim secured across three rounds between 2010 and 2014, with the Austin, Texas-based life-sciences investor holding 19% of EndoStim shares heading into the IPO. The company said the IPO could reach $35.8 million if underwriters exercise their over-allotment.

Wedbush Securities is the lead underwriter alongside Craig-Hallum Capital Group and Roth Capital Partners. EndoStim is aiming to sell 3.2 million shares on the NASDAQ exchange under the STIM symbol, priced between $10 and $12 per share.

EndoStim describes its system in form and function to a pacemaker, with the device delivering low-level electrical stimulation to the lower esophageal sphincter, a muscle at the junction of the esophagus and stomach. The company touts the neurostimulation system as minimally-invasive, reversible and preserving intact the anatomy of the esophagus and stomach.

The company says between 15% and 20% of the population suffer from gastroesophageal reflux disease, which is most often treated with proton pump inhibitors like Nexium and Prilosec, which suppress the production of acid in the stomach. Those drugs do not address the functioning of the LES.

EndoStim received CE Mark approval in 2012 to market its system in Europe and has an additional office in The Hague. The company generated $300,000 in revenue last year, reporting a $7.5 million loss.

The FDA has approved an investigational device exemption that allows EndoStim to conduct a clinical trial in the United States.

3M posts wider-than-forecast losses in Q4 results, will cut 1,500 jobs
3M (NYSE:MMM) posted fourth-quarter results today that matched the revenue consensus forecast on Wall Street but significantly missed on earnings — with the company announcing plans to cut 1,500 jobs amid a reorganization. 3M Healthcare Q4 sales were up 25.4% year-over-year. The Maplewood, Minn.–based company reported profits of $969 million, or $1.66 per share, on… […]
MIT researchers develop light-based device to measure blood glucose
Scientists at the Massachusetts Institute of Technology (MIT) have shown that they can use a type of spectroscopy to replace finger sticks to measure blood glucose levels. Patients with diabetes must test those levels several times a day and more than half of patients don’t test often enough, in part because of the pain and… […]
Soliton touts scar treatment study results
Soliton (NSDQ:SOLY) today announced positive results from treatment of fibrotic scars using its rapid acoustic pulse (RAP) device. The proof-of-concept study, conducted 12 weeks after a single treatment with the device, showed that 10 patients’ keloid and hypertrophic scars were with smaller. Soliton licensed the technology from the University of Texas on behalf of the… […]
January 2020 Issue: The Leadership in Medical Technology Issue
Miles White’s fearless strategy for growing Abbott CVRx CEO Nadim Yared keeps his edge The 10 greatest medtech advances of the 2010s I’m a medtech expert who survived a tumor in my head The next Roaring ’20s The medtech industry received one of the best holiday gifts it could have hoped for just before Congress… […]
Integer adds IPG manufacturing and testing tech to Mexico plant
Integer Holdings (NYSE:ITGR) announced it has added implantable pulse generator (IPG) cleanroom assembly and testing capabilities at its Tijuana-North facility. The plant is the first Class III active-implantable medtech manufacturing site in Mexico to receive FDA approval, according to the Plano, Texas-based company. Integer has added Class 7 and 8 cleanrooms, and manufacturing and capital… […]
FDA issues draft guidance on multi-use arthroscopy tubing sets
The FDA has issued draft guidance on arthroscopy pump tubing sets intended for multiple-patient use. Clinicians often use a single source of irrigation fluid for multiple patients without replacing the source of irrigation fluid or replacing/reprocessing the irrigation tubing system between patients. These devices are designed to deliver irrigation to the surgical site, these devices… […]
How LED light can break down ingestible medical devices
Researchers at the Massachusetts Institute of Technology have developed an approach to break down ingestible medical devices in the gastrointestinal tract. Medical devices can be inserted in the gastrointestinal tract to treat, diagnose or monitor a number of GI disorders. However, the devices have to removed through endoscopic surgery once completed. The MIT researchers developed… […]
New 510(k) boosts iRhythm, Verily efforts for AFib screening
The latest 510(k) clearance for the Verily Study Watch will further the efforts of the Google sister company and iRhythm Technologies (NSDQ:IRTC) to improve atrial fibrillation treatment. Verily — a life science company under Alphabet (NSDQ:GOOGL) — recently received an FDA 510(k) clearance to include an irregular pulse monitor in its Study Watch wearable. “We’ve worked carefully to meet the FDA’s stringent… […]
Argon Medical debuts IVC filter retrieval kits
Argon Medical Devices (Frisco, Texas) said this week that it has launched single-loop and triple-loop retrieval kits for percutaneous removal of inferior vena cava (IVC) filters that are no longer medically required. The kits are indicated for use via a jugular approach and offer the following features: A coil-reinforced outer sheath with the strength needed… […]
NANS 2020: Neuromodulation news you need to know
Neuromodulation devices from companies including Medtronic (NYSE:MDT), Abbott (NYSE:ABT) and SPR Therapeutics are showing promise treating pain. That’s one of the initial takeaways from study results that medical device companies in the neuromodulation space are touting this weekend at NANS 2020 in Las Vegas. NANS is a joint conference of Congress of Neurological Surgeons and the North American Neuromodulation… […]
Injection Molding Principles
Optimizing custom part designs for injection molding requires a thorough understanding of the process and outcomes. In this e-book, you’ll learn about common molding resins, special molding terms you should know, and most importantly, how to optimize your part with undercuts, even walls, drafts, and more. Download this e-book from Xometry to learn more… The […]